Jean Bergeron Selected Research

Jean Bergeron Research Topics

Disease

28	Insulin Resistance 10/2019 - 03/2004
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2002
17	Dyslipidemias (Dyslipidemia) 12/2023 - 01/2003
17	Abdominal Obesity 01/2020 - 02/2002
15	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014 - 04/2003
14	Type 2 Diabetes Mellitus (MODY) 11/2019 - 01/2006
13	Obesity 10/2019 - 06/2002
12	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2022 - 02/2002
11	Hypertriglyceridemia 01/2023 - 07/2002
8	Homozygous Familial Hypercholesterolemia 01/2024 - 08/2016
8	Atherosclerosis 10/2019 - 11/2002
8	Coronary Disease (Coronary Heart Disease) 04/2015 - 02/2002
7	Inflammation (Inflammations) 05/2022 - 10/2005
6	Hypertriglyceridemic Waist 08/2012 - 07/2002
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 07/2002
5	Hyperlipidemias (Hyperlipidemia) 12/2023 - 11/2003
5	Overweight 02/2013 - 10/2006
5	Hyperinsulinism (Hyperinsulinemia) 08/2012 - 02/2002
5	Body Weight (Weight, Body) 10/2005 - 11/2002
4	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2023 - 06/2009
4	Xanthomatosis (Xanthoma) 01/2022 - 01/2018
4	Injection Site Reaction 01/2019 - 07/2012
4	Hypertension (High Blood Pressure) 11/2016 - 12/2004
3	Myocardial Infarction 01/2024 - 04/2010
3	Morbid Obesity 05/2022 - 07/2007
3	Hypercholesterolemia 11/2019 - 03/2003
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 12/2023 - 01/2023
2	Pancreatitis 01/2023 - 01/2019
2	Cognitive Dysfunction 09/2022 - 01/2016
2	Vitamin D Deficiency 01/2020 - 11/2016
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2018
2	Muscular Diseases (Myopathy) 01/2016 - 12/2015
2	Myotoxicity 12/2015 - 12/2014
2	Glucose Intolerance 11/2009 - 09/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2007 - 10/2005
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 08/2007 - 09/2004
1	Stroke (Strokes) 01/2024
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2024
1	Headache (Headaches) 10/2022
1	Appendicitis 10/2022
1	Anorexia Nervosa 10/2022
1	Peritonitis 10/2022

Drug/Important Bio-Agent (IBA)

33	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2002
29	oxidized low density lipoproteinIBA 01/2024 - 02/2002
21	LipidsIBA 01/2024 - 01/2003
18	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 03/2005
18	Lipoproteins (Lipoprotein)IBA 02/2018 - 02/2002
17	HDL CholesterolIBA 10/2018 - 02/2002
14	LDL CholesterolIBA 03/2024 - 10/2007
14	Insulin (Novolin)FDA Link 01/2018 - 07/2002
14	ApolipoproteinsIBA 06/2017 - 07/2002
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 03/2003
11	C-Reactive ProteinIBA 01/2018 - 03/2003
10	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 02/2002
10	CholesterolIBA 10/2018 - 02/2002
9	Apolipoproteins B (ApoB)IBA 01/2019 - 02/2002
8	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2003
7	LDL Receptors (LDL Receptor)IBA 01/2022 - 02/2002
7	HDL LipoproteinsIBA 10/2018 - 06/2002
7	Adenosine Triphosphate (ATP)IBA 12/2014 - 01/2006
6	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2023 - 06/2002
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2007
5	Vitamin D FDA LinkGeneric 12/2023 - 06/2015
5	evolocumabIBA 12/2023 - 10/2020
5	alirocumabIBA 11/2019 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 07/2018 - 03/2003
4	hydroxide ionIBA 01/2020 - 06/2015
4	AdiponectinIBA 01/2018 - 02/2005
4	Apolipoprotein B-48IBA 06/2017 - 12/2003
4	Apolipoprotein B-100 (Apo B 100)IBA 02/2008 - 12/2003
3	Messenger RNA (mRNA)IBA 02/2018 - 04/2010
3	Dextran SulfateIBA 02/2018 - 08/2016
3	Oxidoreductases (Dehydrogenase)IBA 12/2014 - 02/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 10/2006
3	Atorvastatin (Lipitor)FDA Link 03/2008 - 03/2003
3	Fibrinogen (Factor I)FDA Link 10/2005 - 03/2002
2	Proprotein Convertase 9IBA 06/2022 - 10/2014
2	LeptinIBA 05/2022 - 01/2020
2	Plasminogen Activator Inhibitor 1IBA 05/2022 - 04/2010
2	C-PeptideIBA 09/2019 - 06/2015
2	25-hydroxyvitamin DIBA 09/2019 - 06/2015
2	Insulin-Like Growth Factor Binding Protein 2IBA 01/2019 - 12/2014
2	HDL-triglycerideIBA 01/2018 - 08/2008
2	Lipoprotein(a)IBA 01/2018 - 03/2002
2	Cholesterol Ester Transfer ProteinsIBA 05/2015 - 06/2004
2	Nonesterified Fatty Acids (NEFA)IBA 10/2013 - 02/2009
2	Fenofibrate (CiL)FDA LinkGeneric 03/2008 - 02/2008
2	Fibric Acids (Fibrates)IBA 03/2008 - 02/2008
2	VLDL LipoproteinsIBA 08/2007 - 02/2004
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2007 - 01/2007
2	Dietary Fats (Dietary Fat)IBA 06/2006 - 03/2004
2	Lipase (Acid Lipase)FDA Link 07/2005 - 01/2003
2	Simvastatin (Zocor)FDA LinkGeneric 05/2004 - 02/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2004 - 03/2003
2	Apolipoproteins E (ApoE)IBA 01/2004 - 02/2002
1	omega-Chloroacetophenone (Mace)IBA 01/2024
1	AngiopoietinsIBA 01/2023
1	evinacumabIBA 01/2023

Therapy/Procedure

9	Therapeutics 01/2024 - 11/2002
4	Blood Component Removal (Apheresis) 02/2018 - 08/2016